Research and Healthcare Resources (RAHR) for Technology Outcomes

Genomics England is a company wholly owned and funded by the Department for Health & Social Care. GEL's vision is a world where everyone benefits from genomic healthcare. Where genomic data and research are translated rapidly into clinical interpretations, insights, and actions, driving better patient outcomes and lower healthcare costs.

To capitalise on the opportunities within the genomic healthcare sector, and to support the delivery of the government's strategy over the next several years, GEL will be developing its services to increase its value offering and keep pace within rapidly growing biotech and life science sectors.

Delivering our aims will involve multiple projects and programmes focused on making improvements in different areas. GEL's internal expertise will not always be sufficient to realise the required outcomes therefore GEL will draw on external partners with the necessary expertise and capacity to support delivery by establishing a framework of partners to supply the following types of services:

Data services

Bioengineering services

Engineering services

IT strategy and architecture services Management services

Additional specialist technology and healthcare resources

This Prior Information Notice is issued to notify all interested potential partners of a potential procurement to establish a framework agreement in line with Regulation 33 of the Public Contracts Regulations 2015. It is envisaged that the framework would be in place for a minimum of 2 years (potentially up to 4 years). The framework will encompass Research and Healthcare Resource providers to deliver technology outcome-based projects.

The framework will have multiple supplier partners and have a number of different Lots. Suppliers will be able to bid for one or multiple Lots either as a single entity or in collaboration with other organisations. This is not a call for competition and a further Contract Notice will be issued to begin a formal procurement procedure.

Interested suppliers are invited to view more information regarding the opportunity and respond to our Market Consultation Document. You may need to register on Bravo if you have not already done so: https://public.bravosolution.co.uk/genomicsengland/web/login.html . Once registered, please search for the project under code project_846

A market consultation event will be held on 18 April 2023 and suppliers registered on the e-tendering portal will be contacted with more information regarding this.